Azacitidine: a review of its use in the management of myelodysplastic syndromes/acute myeloid leukaemia.
about
Trials with 'epigenetic' drugs: an updateDecitabine: a review of its use in older patients with acute myeloid leukaemia.The epigenetic drug 5-azacytidine interferes with cholesterol and lipid metabolismAerosol azacytidine inhibits orthotopic lung cancers in mice through Its DNA demethylation and gene reactivation effects.5-azacytidine inhibits nonsense-mediated decay in a MYC-dependent fashion.Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome.Decitabine in the treatment of acute myeloid leukemia in elderly patients.Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia.Role of cytidine deaminase in toxicity and efficacy of nucleosidic analogs.Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia.Sweet's syndrome associated with clonal hematopoiesis of indeterminate potential responsive to 5-azacitidine.Update on optimal management of acute myeloid leukemiaAzacitidine as salvage therapy in elderly patients with relapsed acute myeloid leukemia after autologous transplantation.Systematic review of azacitidine regimens in myelodysplastic syndrome and acute myeloid leukemia.Necrotizing fasciitis in two patients with myelodysplastic syndrome treated with azacitidine.Topical 5-azacytidine accelerates skin wound healing in rats.
P2860
Q27000542-0A3C4B24-3473-4475-B169-EEF83B130CD0Q33407030-93E37EDE-D234-4436-91D5-FA0E4BE9E66FQ33846421-88350751-8DFB-469F-9BB7-6E76C48C1951Q34407810-DBE75A93-F4B6-4ABB-B12D-83FD4B2353E0Q34443734-31A2C0A7-1A59-4FA1-96D1-836D805C25DDQ35224437-1B2B34DB-8C0A-4F67-B878-349AC0983C8DQ37568244-B13EA2F4-D8D6-40A4-B264-E8EFC947888EQ37622957-F7DC60F6-E0CC-4413-B357-579CE1C4AA73Q38286242-6827C546-68F2-40F9-AFE1-398C969B2453Q38837834-6D076EF9-4723-4971-9461-8996E26FC317Q39137715-56275F76-9758-41AB-B441-18A2B6A5795FQ41894404-5DAD6392-636B-4904-A248-0B05DF50FA3EQ45656971-BFEE5054-E737-4275-91B1-DF11737668EBQ49401381-69197A51-D0B0-454C-954C-F007D1EECBB1Q51725692-9556A993-A33B-4F97-930B-BC7BC1560F19Q53059476-A59E3F13-9FF5-4D7A-ABAB-1E06155EE6CC
P2860
Azacitidine: a review of its use in the management of myelodysplastic syndromes/acute myeloid leukaemia.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Azacitidine: a review of its u ...... romes/acute myeloid leukaemia.
@ast
Azacitidine: a review of its u ...... romes/acute myeloid leukaemia.
@en
Azacitidine: a review of its u ...... romes/acute myeloid leukaemia.
@nl
type
label
Azacitidine: a review of its u ...... romes/acute myeloid leukaemia.
@ast
Azacitidine: a review of its u ...... romes/acute myeloid leukaemia.
@en
Azacitidine: a review of its u ...... romes/acute myeloid leukaemia.
@nl
prefLabel
Azacitidine: a review of its u ...... romes/acute myeloid leukaemia.
@ast
Azacitidine: a review of its u ...... romes/acute myeloid leukaemia.
@en
Azacitidine: a review of its u ...... romes/acute myeloid leukaemia.
@nl
P2860
P1433
P1476
Azacitidine: a review of its u ...... romes/acute myeloid leukaemia.
@en
P2860
P304
P356
10.2165/11209430-000000000-00000
P577
2012-05-01T00:00:00Z
P6179
1038632820